News
Alpha-1 Foundation Applauds NY Times Story on COPD
MIAMI, FL – John W. Walsh, president and CEO of the Alpha-1 Foundation, today applauded The New York Times for its front-page feature story on COPD (Chronic Obstructive Pulmonary Disease).
The Times identifies smoking as the leading cause of COPD, but also points out that genes and chronic inflammation are the latest suspects for researchers as they focus on the underlying causes. Alpha-1 Antitrypsin Deficiency (Alpha-1) is identified as the “genetic disorder known to cause emphysema.”
Walsh said, “We applaud The Times for its focus on COPD and its presentation of a balanced story. We especially appreciate its spotlighting today’s cutting-edge research on genetic factors, which will accelerate targeted therapies for COPD patients.”
